Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Kyverna Therapeutics · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
autoimmune-diseasemsmultiple-sclerosis
multiple sclerosis, primary progressive, multiple sclerosis, secondary progressive, multiple sclerosis, ms, kyv-101, autoimmune disease, anti-cd19 car-t therapy, cellular therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876724
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.